Purchase Order 75F40120P00473
- Not listed
- This contract award from the Department of Health and Human Services Food and Drug Administration is for the purchase of laboratory equipment by Adaptive Biotechnologies Corporation, doing business as Adaptive. The $126,152.20 firm fixed price purchase order was set aside for small businesses and awarded on September 11, 2019 with a completion date of October 10, 2019. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products, including specialized testing...
- This is a firm fixed price purchase order valued at $234,900.00 awarded by the National Institutes of Health (NIH) Clinical Center to Adaptive Biotechnologies Corporation, doing business as Adaptive, with a period of performance ending on September 30, 2024. The contract does not have a set-aside designation. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products, including immunosequencing, DNA extraction, and COVID-19 research services for the...
- The Department of Health and Human Services (HHS) National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $61,150.00 firm fixed price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, for SARS-COV-2 immunosequencing testing services. The contract has a performance period through September 30, 2024 and was awarded on May 7, 2024. Adaptive has previously provided specialized testing and genomic sequencing services to HHS,...
- This is a $12,300 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Adaptive Biotechnologies Corporation (Adaptive) for "IMMUNOSEQ MMTCRB SEQUENCING SERVICE". The contract has an ultimate completion date of December 31, 2023 and was awarded on September 19, 2023 without a set-aside designation. Adaptive, a for-profit organization, has previously...
- This $19,835 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Adaptive Biotechnologies Corporation (Adaptive) for COVID-19 research and B-cell sequencing services. The contract has a period of performance through March 24, 2021. Adaptive is a commercial provider of immune-driven medicine services and products, and has previously received federal contracts and...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Adaptive Biotechnologies Corporation (also doing business as Adaptive) for IMMUNOSEQ MMTCRB SERVICE. The contract, valued at $12,200.00, does not have a set-aside designation. Through this award, Adaptive Biotechnologies will provide specialized sequencing and testing services to support HHS research programs. Adaptive...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,690 firm fixed-price purchase order to Adaptive Biotechnologies Corporation (doing business as Adaptive) for ImmunoSEQ sequencing services. The contract has an ultimate completion date of December 20, 2024. Adaptive is a commercial provider of immune-driven medicine services and products, and has previously received federal contracts and grants from the Department of Health and Human Services (HHS), Department...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Adaptive Biotechnologies Corporation ("Adaptive") for immunosequencing extraction services. The $12,750 contract was awarded on December 10, 2019 with a completion date of December 10, 2020. Adaptive is a commercial provider of immune-driven medicine services and products. The company has...
- This is a firm fixed-price purchase order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Adaptive Biotechnologies Corporation (doing business as Adaptive) for $6,200. The contract is for repertoire sequencing services, which involve analyzing the adaptive immune system's T-cell and B-cell receptors. This award supports NIAID's research programs. Adaptive, a commercial provider of immune-driven medicine,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $20,197.60 firm-fixed-price purchase order for DNA sequencing services to Adaptive Biotechnologies Corporation, doing business as Adaptive. The contract has no set-aside designation and was completed on June 21, 2019. Adaptive is a commercial provider of immune-driven medicine services and products, and has previously received federal contracts from the...
This is a $90,624.80 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Adaptive Biotechnologies Corporation (Adaptive) for the provision of Adaptive Biotechnologies kits. The contract has a completion date of October 30, 2020. Adaptive is a commercial provider of immune-driven medicine services and products, and this award supports the company's provision of specialized testing and genomic sequencing services to the FDA. The contract is set aside for small businesses. Adaptive has previously received other federal prime contract awards and grant funding from the Department of Health and Human Services, Department of Veterans Affairs, and Defense Health Agency for services such as immunosequencing, DNA extraction, COVID-19 research, and minimal residual disease testing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($9k) | 7/13/23 | |
| Not listed | Not listed | $99.4k | 8/21/20 |